title: [Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].
abstract: Case report of one idiopathic juxtafoveal telangiectasis (IJT) 1A patient whose right eye was treated with a 4 mg intravitreal triamcinolone acetonide injection. The outcome was evaluated by visual acuity and optic coherence tomography. The visual acuity and the caliper retinal thickness before triamcinolone injection were respectively 20/100 and 569 microm, and 20/60 and 371 microm after three weeks and 20/100 and 614 microm after six week of follow-up. The stabilization of the vascular wall due to the intravitreal triamcinolone injection leads to a transitory improvement in vision and reduction in macular edema in the TJI 1A eyes. No permanent help by the photocoagulation could be shown.
authors.affiliation: Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil. omaiausp@uol.com.br
authors.forename: Otacílio Oliveira
authors.initials: OO
authors.lastname: Maia
authors.forename: Walter Yukihiko
authors.initials: WY
authors.lastname: Takahashi
authors.forename: Maria Teresa Brizzi C
authors.initials: MT
authors.lastname: Bonanomi
authors.forename: Vinícius Paganini
authors.initials: VP
authors.lastname: Nascimento
authors.forename: Carlos Sérgio Nascimento de
authors.initials: CS
authors.lastname: Melo
mesh_terms: D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000188:drug therapy*; D012171:Retinal Vessels / Q000187:drug effects* / Q000473:pathology; D013684:Telangiectasis / Q000628:therapy*; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014792:Visual Acuity; D014822:Vitreous Body / Q000187:drug effects
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide